AMLX: Amylyx Pharmaceuticals Inc. Stocks News on January 22, 2025

AMLX

MT Newswires

a day ago

Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

AMLX

Business Wire

a day ago

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

AMLX

MT Newswires

12 days ago

Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

AMLX

Business Wire

12 days ago

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

AMLX

MT Newswires

12 days ago

Amylyx Pharmaceuticals Launches Stock Offering

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

AMLX

Business Wire

13 days ago

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

Cerus And 2 Other US Penny Stocks With Promising Potential

AMLX

Simply Wall St.

16 days ago

Cerus And 2 Other US Penny Stocks With Promising Potential

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer

AMLX

Business Wire

16 days ago

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer

AMLX

MT Newswires

23 days ago

Amylyx Pharmaceuticals, Gubra Collaborate on GLP-1 Therapy Development

AMLX

Insider Monkey

23 days ago

Why Is Amylyx Pharmaceuticals (AMLX) Among the Best Biotech Penny Stocks to Invest in Now?

Amylyx announces design of LUCIDITY clinical trial

AMLX

TipRanks

2 months ago

Amylyx announces design of LUCIDITY clinical trial

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

AMLX

Business Wire

2 months ago

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

AMLX

Business Wire

2 months ago

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

AMLX

MT Newswires

2 months ago

Baird Upgrades Amylyx Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $11 From $3

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)

AMLX

Simply Wall St.

2 months ago

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)

AMLX

GuruFocus.com

2 months ago

Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

AMLX

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

AMLX

Business Wire

2 months ago

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

AMLX

Business Wire

3 months ago

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc

AMLX

GuruFocus.com

3 months ago

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc

AMLX

MT Newswires

3 months ago

Amylyx Pharmaceuticals Shares Rise After BofA Upgrade

AMLX

MT Newswires

3 months ago

BofA Securities Upgrades Amylyx Pharmaceuticals to Buy From Neutral, Price Target is $10

October 2024's US Penny Stocks Poised For Growth

AMLX

Simply Wall St.

3 months ago

October 2024's US Penny Stocks Poised For Growth

AMLX

Insider Monkey

3 months ago

Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial

AMLX

Clinical Trials Arena

3 months ago

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week

AMLX

Motley Fool

3 months ago

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug

AMLX

BioPharma Dive

3 months ago

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug

AMLX

MT Newswires

3 months ago

Amylyx Pharmaceuticals Shares Jump After Wolfram Syndrome Treatment Study Shows Improvement

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome

AMLX

Business Wire

3 months ago

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024

AMLX

Business Wire

3 months ago

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024

AMLX

GuruFocus.com

3 months ago

Amylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Call Highlights: Strategic Pipeline ...

AMLX

GuruFocus.com

4 months ago

Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)

AMLX

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 09/06/2024

AMLX

GuruFocus.com

5 months ago

Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration

AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration

AMLX

Simply Wall St.

5 months ago

We Think Amylyx Pharmaceuticals (NASDAQ:AMLX) Can Easily Afford To Drive Business Growth

Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

AMLX

Business Wire

5 months ago

Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates

AMLX

Zacks

5 months ago

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates

Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

EC grants orphan drug status for Amylyx’s Wolfram treatment

AMLX

Pharmaceutical Technology

6 months ago

EC grants orphan drug status for Amylyx’s Wolfram treatment

AMLX

MT Newswires

6 months ago

Amylyx Pharmaceuticals' Receives EU Orphan Designation for Potential Wolfram Syndrome Drug

Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome

AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome

AMLX

MT Newswires

6 months ago

Goldman Sachs Adjusts Price Target on Amylyx Pharmaceuticals to $4 From $3, Maintains Neutral Rating

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

AMLX

Clinical Trials Arena

6 months ago

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

AMLX

MT Newswires

6 months ago

Amylyx Pharmaceuticals Acquires Avexitide From Eiger BioPharmaceuticals for $35 Million

Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation

AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation

Amylyx, with GLP-1 buy, doubles down on blood sugar drugs

AMLX

BioPharma Dive

6 months ago

Amylyx, with GLP-1 buy, doubles down on blood sugar drugs

Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide

AMLX

Business Wire

6 months ago

Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide

Amylyx ventures into metabolic diseases market with $35.1m deal

AMLX

Pharmaceutical Technology

7 months ago

Amylyx ventures into metabolic diseases market with $35.1m deal

Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

AMLX

MT Newswires

8 months ago

Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating

Amylyx Pharmaceuticals Reports Q1 2024 Financial Results

AMLX

GuruFocus.com

8 months ago

Amylyx Pharmaceuticals Reports Q1 2024 Financial Results

AMLX

Insider Monkey

8 months ago

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript

AMLX

Zacks

8 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates

Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results

AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results

Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference

AMLX

Business Wire

8 months ago

Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference

Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

AMLX

Business Wire

9 months ago

Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

Trials to watch: Four ALS drugs to keep an eye on

AMLX

Clinical Trials Arena

9 months ago

Trials to watch: Four ALS drugs to keep an eye on

AMLX

Zacks

9 months ago

The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals

Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder

AMLX

Benzinga

9 months ago

Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder

Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News

AMLX

Zacks

9 months ago

Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News

Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome

AMLX

Business Wire

9 months ago

Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024

AMLX

Business Wire

9 months ago

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024

AMLX

Simply Wall St.

10 months ago

Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers

AMLX

Zacks

10 months ago

Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%

ALS drug will be pulled from US market after study showed patients didn't benefit

AMLX

Associated Press Finance

10 months ago

ALS drug will be pulled from US market after study showed patients didn't benefit

AMLX

Reuters

10 months ago

UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets

Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market

AMLX

Barrons.com

10 months ago

Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market

AMLX

Reuters

10 months ago

Amylyx Pharmaceuticals to remove ALS drug from US, Canada markets

Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy

AMLX

Business Wire

10 months ago

Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy

Amylyx to pull ALS drug from market in rare move

AMLX

BioPharma Dive

10 months ago

Amylyx to pull ALS drug from market in rare move

European study finds popular ALS drug ineffective

AMLX

BioPharma Dive

10 months ago

European study finds popular ALS drug ineffective

AMLX

Zacks

10 months ago

Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More

Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors

AMLX

Business Wire

10 months ago

Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors

Analysts on Wall Street Lower Ratings for These 10 Stocks

AMLX

Insider Monkey

10 months ago

Analysts on Wall Street Lower Ratings for These 10 Stocks

After surprise trial failure, ALS doctors brace for one less treatment option

AMLX

BioPharma Dive

10 months ago

After surprise trial failure, ALS doctors brace for one less treatment option

AMLX

Zacks

10 months ago

Amylyx's (AMLX) ALS Drug Fails Pivotal Study, Stock Down 82%

Amylyx CEOs look for a path forward following major setback

AMLX

BioPharma Dive

10 months ago

Amylyx CEOs look for a path forward following major setback

AMLX

Simply Wall St.

10 months ago

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Analysts Are Reducing Their Forecasts For This Year

Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.

AMLX

The Wall Street Journal

10 months ago

Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.

Amylyx Stock Wipes Out Nearly All Of Its Value, Crashing 82%, After Pivotal ALS Drug Failure

AMLX

Investor's Business Daily

10 months ago

Amylyx Stock Wipes Out Nearly All Of Its Value, Crashing 82%, After Pivotal ALS Drug Failure

Maker of much-debated ALS drug says it may stop selling it after study showed it didn't work

AMLX

Associated Press Finance

10 months ago

Maker of much-debated ALS drug says it may stop selling it after study showed it didn't work

Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future

AMLX

Barrons.com

10 months ago

Amylyx’s ALS Drug Fails Trial, Raising Questions About Company’s Future

AMLX

Insider Monkey

10 months ago

10 Biotech Stocks with Huge Potential

AMLX

Reuters

10 months ago

Amylyx's ALS drug fails in late-stage confirmatory study

Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS

AMLX

Business Wire

10 months ago

Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS

Amylyx ALS drug fails crucial study, putting company’s future in doubt

AMLX

BioPharma Dive

10 months ago

Amylyx ALS drug fails crucial study, putting company’s future in doubt

7 Oversold Russell 2000 Stocks to Add to Your February Buy List

AMLX

InvestorPlace

a year ago

7 Oversold Russell 2000 Stocks to Add to Your February Buy List

AMLX

Simply Wall St.

a year ago

Do Its Financials Have Any Role To Play In Driving Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Stock Up Recently?

Earnings Miss: Amylyx Pharmaceuticals, Inc. Missed EPS By 22% And Analysts Are Revising Their Forecasts

AMLX

Simply Wall St.

a year ago

Earnings Miss: Amylyx Pharmaceuticals, Inc. Missed EPS By 22% And Analysts Are Revising Their Forecasts

Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

AMLX

Insider Monkey

a year ago

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript

Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter

AMLX

Investor's Business Daily

a year ago

Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter

AMLX

Zacks

a year ago

Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q4 Earnings Estimates

AMLX

GuruFocus.com

a year ago

Amylyx Pharmaceuticals Inc (AMLX) Reports Robust Revenue Growth and Net Income for Full Year 2023

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

Amylyx Pharmaceuticals to Present Updates on its AMX0114 and RELYVRIO® Programs in ALS at the 2024 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference

AMLX

Business Wire

a year ago

Amylyx Pharmaceuticals to Present Updates on its AMX0114 and RELYVRIO® Programs in ALS at the 2024 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference

Get Rich Quick With These 3 Biotech Stocks to Buy Now

AMLX

InvestorPlace

a year ago

Latest Amylyx Pharmaceuticals Inc. (AMLX) News on January 22, 2025

Share on Social Networks: